FHIR CI-Build

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

Example MedicationDispense/meddisp0315 (Narrative)

Pharmacy Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Encounter, Patient, Practitioner

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationDispense.

Generated Narrative: MedicationDispense meddisp0315

status: in-progress

Medications

-Reference
* amylase / cellulase / hyoscyamine / lipase / phenyltoloxamine / protease Oral Capsule

subject: Donald Duck

Performers

-Actor
* Practitioner Rob van den Berk (official)

authorizingPrescription: MedicationRequest: identifier = http://www.bmc.nl/portal/prescriptions#12345689 (use: official, ); status = completed; intent = order; authoredOn = 2015-01-15

type: Refill - Part Fill

quantity: 30(unit TAB from http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm) (Details: Orderable Drug Form codeTAB = 'Tablet')

daysSupply: 10 Day (Details: UCUM coded = 'd')

whenPrepared: 2015-06-25T07:13:00+05:00

whenHandedOver: 2015-06-26T07:13:00+05:00

dosageInstruction

sequence: 1

text: 0.25mg PO every 6-12 hours as needed for menses from Jan 15-20, 2015. Do not exceed more than 4mg per day

additionalInstruction: Warning. May cause drowsiness. If affected do not drive or operate machinery. Avoid alcoholic drink (qualifier value)

timing: Once per 6-12 hours

asNeededFor: Dysmenorrhea (disorder)

route: Oral Route

DoseAndRates

-TypeDose[x]
* Ordered 1 TAB (Details: Orderable Drug Form codeTAB = 'Tablet')

Generated Narrative: Medication #med0314

code: amylase / cellulase / hyoscyamine / lipase / phenyltoloxamine / protease Oral Capsule

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.